![]() |
市场调查报告书
商品编码
1454071
防过时的药品标籤市场预测至 2030 年:按标籤类型、印刷类型、材料、技术、应用、最终用户和地区进行的全球分析Future Proof Pharma Labels Market Forecasts to 2030 - Global Analysis By Labeling Type, Printing Type, Material, Technology, Application, End User and By Geography |
根据 Stratistics MRC 的数据,面向防过时的药品标籤的全球市场在预测期内将以 17.1% 的复合年增长率成长。
防过时的药品标籤是旨在承受未来监管变化、技术进步和不断发展的行业标准的药品标籤。这些标籤旨在维持长期的合规性和有效性,并准确地向医疗保健专业人员和患者传达重要讯息,例如药物的剂量和给药、警告和有效期。
据世界卫生组织 (WHO) 称,假冒产品每年给製药业造成 750 亿美元的损失。
更加关注病患安全
该市场面向未来的策略越来越注重改善标籤设计和资讯清晰度,以减少用药错误并改善患者治疗结果。重点包括用户友好的说明、清晰的用法和剂量资讯以及有关潜在风险的明确警告。此外,还整合了用于获取详细药物资讯的二维码等技术进步,以进一步增强安全措施。
整合复杂度
由于需要高效的防伪解决方案、遵守严格的法规以及引入 RFID 技术来监控药品的品质和流动,製药业的市场整合涉及多种复杂性。此外,在某些地区,分销过程是手动管理的,因此难以管理适当的库存和有效期。这种复杂性凸显了实施和管理面向未来的药品标籤的挑战,特别是在流通结构和手动流程复杂的地区。
准确药物资讯的需求日益增长
由于监管收紧、对病人安全的关注和技术进步,市场对准确药物资讯的需求日益增长。追踪技术和智慧标籤的整合增强了供应链的可视性和以患者为中心的标籤解决方案。此外,数位印刷技术的采用正在彻底改变市场,使製药公司能够创建耐用、防篡改且包含动态资料的标籤。
认识有限
这主要是由于标籤法规和技术的复杂性和不断发展的性质。许多製药公司,尤其是小型製药公司,可能没有完全了解面向防过时解决方案的好处和要求。资源和专业知识有限的小型製药公司可能对面向防过时解决方案的好处和要求了解不足。此外,全球监管环境的多样化进一步使意识工作变得更加复杂。
COVID-19 大流行防过时的药品标籤市场产生了重大影响,促使人们更加关注安全性、可追溯性和监管合规性。随着製药业面临前所未有的挑战,对确保产品真实性、防篡改以及追踪疫苗分销和打击假药的连续性的标籤的需求不断增长。此外,疫情也加速了二维码和RFID技术等数位解决方案的采用,使供应链更具弹性并实现远端监控。
感压标籤市场预计将在预测期内成为最大的市场
预计感压标籤市场在预测期内将是最大的市场。由于材料科学和印刷技术的进步,感压标籤已准备好满足不断变化的行业需求,包括序列化和防伪措施。它易于使用且能够黏附在各种表面上,使其成为药品包装的最爱,可提高效率并在整个供应链中实现准确的产品识别和追踪。
预计弹性凸版印刷产业在预测期内的复合年增长率最高
预计弹性凸版印刷产业在预测期内的复合年增长率最高。随着可追溯性、安全性和法规遵循的要求不断提高,弹性凸版印刷提供了能够承受恶劣环境条件的高品质、耐用标籤。此外,弹性凸版印刷技术的进步,例如改进的油墨配方和基材相容性,可确保药品标籤符合不断发展的行业标准。
由于采用智慧标籤和防篡改功能等创新标籤解决方案,预计北美在预测期内将占据最大的市场占有率。此外,对个人化医疗和追踪功能不断增长的需求进一步推动了市场扩张。由于强调提高整个供应链的效率和安全性,药品标籤市场预计在未来几年将持续成长和发展。
预计亚太地区在预测期内将维持最高的复合年增长率。由于人口成长、医疗保健意识增强和收入水准提高等因素,该地区的药品消费正在增加。药品消费的增加直接推动了对药品标籤的需求。製药业越来越关注病人安全,导致对有助于准确剂量和给药说明的标籤的需求增加。
According to Stratistics MRC, the Global Future Proof Pharma Labels Market is growing at a CAGR of 17.1% during the forecast period. Future Proof Pharma Labels is pharmaceutical labels designed to withstand future regulatory changes, technological advancements, and evolving industry standards. These labels are intended to remain compliant and effective over time, ensuring that important information such as drug dosage, administration instructions, warnings, and expiration dates are accurately conveyed to healthcare professionals and patients.
According to the World Health Organization, globally, counterfeiting costs the pharma industry USD 75 billion every year.
Growing emphasis on patient safety
Future-proofing strategies in this market increasingly focus on enhancing label designs and information clarity to reduce medication errors and improve patient outcomes. Emphasis is placed on incorporating user-friendly instructions, clear dosage information, and prominent warnings about potential risks. Additionally, advancements in technology, such as QR codes for accessing detailed medication information, are being integrated to further enhance safety measures.
Complexity of integration
The integration of market in the pharmaceutical industry presents several complexities due to the need for efficient anti-counterfeiting solutions, adherence to stringent regulations, and the deployment of RFID technology for monitoring drug quality and movement. Additionally, the distribution process in certain regions is managed manually, leading to difficulties in managing proper inventory and expiry dates. These complexities highlight the challenges in implementing and managing future-proof pharma labels, especially in regions with complex distribution structures and manual processes
Rising need for accurate medication information
The market is witnessing a rising need for accurate medication information driven by increasing regulations, patient safety focus, and technological advancements. The integration of track-and-trace technologies and smart labels is enhancing supply chain visibility and patient-centric labeling solutions. Furthermore, the adoption of digital printing technologies is revolutionizing the market, allowing pharmaceutical companies to produce durable, tamper-evident labels with dynamic data.
Limited awareness
Limited awareness persists in the market, primarily due to the complex and evolving nature of labeling regulations and technologies. Many pharmaceutical companies, especially smaller ones, may not be fully informed about the benefits and requirements of future-proof labeling solutions. Smaller pharmaceutical companies may not be fully informed about the benefits and requirements of future-proof labeling solutions due to limited resources and expertise. Moreover, the diverse global regulatory landscape further complicates awareness efforts.
The COVID-19 pandemic has significantly impacted the Future Proof Pharma Labels Market, prompting a heightened focus on safety, traceability, and regulatory compliance. With the pharmaceutical industry facing unprecedented challenges, there's a growing demand for labels that ensure product authenticity, tamper-evidence, and serialization to track vaccine distribution and combat counterfeit drugs. Moreover, the pandemic has accelerated the adoption of digital solutions, such as QR codes and RFID technology, enhancing supply chain resilience and enabling remote monitoring.
The pressure-sensitive labels segment is expected to be the largest during the forecast period
The pressure-sensitive labels segment is expected to be the largest during the forecast period. With advancements in material science and printing technologies, pressure-sensitive labels are poised to meet evolving industry needs, including serialization and anti-counterfeiting measures. Their ease of application and ability to adhere to various surfaces make them a preferred choice for pharmaceutical packaging, enhancing efficiency and ensuring accurate product identification and tracking throughout the supply chain.
The flexographic printing segment is expected to have the highest CAGR during the forecast period
The flexographic printing segment is expected to have the highest CAGR during the forecast period. With increasing demands for traceability, security, and regulatory compliance, flexographic printing offers high-quality, durable labels capable of withstanding stringent environmental conditions. Moreover, advancements in flexographic technology, such as improved ink formulations and substrate compatibility, ensure that pharmaceutical labels meet evolving industry standards.
North America is projected to hold the largest market share during the forecast period due to their adoption of innovative labeling solutions, including smart labels and tamper-evident features. Moreover, rising demand for personalized medicine and track-and-trace capabilities further fuels market expansion. With a focus on enhancing efficiency and safety throughout the supply chain, the pharmaceutical labels market in is expected to experience sustained growth and evolution in the coming years.
Asia Pacific is projected to hold the highest CAGR over the forecast period. The region is witnessing a rise in pharmaceutical consumption due to factors such as population growth, increasing healthcare awareness, and rising income levels. This growth in pharmaceutical consumption directly contributes to the demand for pharmaceutical labels. There is a growing emphasis on patient safety in the pharmaceutical industry, leading to increased demand for labels that facilitate accurate medication administration and dosage instructions.
Key players in the market
Some of the key players in Future Proof Pharma Labels market include Denny Bros Ltd., Loftware, Inc., R.R. Donnelley & Sons Company, 3M Company, CCL Industries Inc., UPM Raflatac, Inc., Essentra PLC, WS Packaging Group, Inc., Schreiner Group GmbH & Co. KG, Covectra, Inc., Avery Dennison Corporation, Taylor Communications, Zebra Technologies, Honeywell, Graphic Label, Inc., DuPont and Sato Corporation.
In July 2023, CCL Industries Inc., has announced the acquisition of Faubel & Co. Nachfolger GmbH ("Faubel"), a specialist in labels for pharmaceutical clinical trials. The acquisition marks a strategic move by CCL Industries to build a stronger global presence in the healthcare sector and positions the company as a key player in clinical trials labeling.
In March 2023, 3M announced a collaboration with Guardhat, an industry-leading connected safety software company. Given the importance of connectivity as a key ingredient in safety programs, 3M is transferring its Safety Inspection Management (SIM) software to Guardhat.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.